{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:14:18Z","timestamp":1794370458338,"version":"4.9.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although the importance of virus-specific cytotoxic T lymphocytes (CTL) in virus clearance is evident in COVID-19, the characteristics of virus-specific CTLs related to disease severity have not been fully explored. Here we show that the phenotype of virus-specific CTLs against immunoprevalent epitopes in COVID-19 convalescents might differ according to the course of the disease. We establish a cellular screening method that uses artificial antigen presenting cells, expressing HLA-A<jats:sup>*<\/jats:sup>24:02, the costimulatory molecule 4-1BBL, SARS-CoV-2 structural proteins S, M, and N and non-structural proteins ORF3a and nsp6\/ORF1a. The screen implicates SARS-CoV-2 M protein as a frequent target of IFN\u03b3 secreting CD8<jats:sup>+<\/jats:sup> T cells, and identifies M<jats:sub>198\u2013206<\/jats:sub> as an immunoprevalent epitope in our cohort of HLA-A<jats:sup>*<\/jats:sup>24:02 positive convalescent COVID-19 patients recovering from mild, moderate and severe disease. Further exploration of M<jats:sub>198\u2013206<\/jats:sub>-specific CD8<jats:sup>+<\/jats:sup> T cells with single cell RNA sequencing reveals public TCRs in virus-specific CD8<jats:sup>+<\/jats:sup> T cells, and shows an exhausted phenotype with less differentiated status in cells from the severe group compared to cells from the moderate group. In summary, this study describes a method to identify T cell epitopes, indicate that dysfunction of virus-specific CTLs might be an important determinant of clinical outcomes.<\/jats:p>","DOI":"10.1038\/s41467-022-34655-1","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:03:43Z","timestamp":1671188623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2116-0340","authenticated-orcid":false,"given":"Hideki","family":"Ogura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-2871","authenticated-orcid":false,"given":"Xiuyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3731-1702","authenticated-orcid":false,"given":"Mizuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8635-6416","authenticated-orcid":false,"given":"Yoshio","family":"Takesue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5387-0187","authenticated-orcid":false,"given":"Aoi","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadayuki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4236","authenticated-orcid":false,"given":"Takamasa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Mambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromoto","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-6925","authenticated-orcid":false,"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6389-7036","authenticated-orcid":false,"given":"Jun-ichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-6917","authenticated-orcid":false,"given":"Sho","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-3354","authenticated-orcid":false,"given":"Satoshi","family":"Ishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"34655_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10654-020-00698-1","volume":"35","author":"AT Levin","year":"2020","unstructured":"Levin, A. T. et al. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur. J. Epidemiol. 35, 1123\u20131138 (2020).","journal-title":"Eur. J. Epidemiol."},{"key":"34655_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41586-022-04576-6","volume":"607","author":"A Kousathanas","year":"2022","unstructured":"Kousathanas, A. et al. Whole genome sequencing reveals host factors underlying critical Covid-19. Nature 607, 97\u2013103 (2022).","journal-title":"Nature"},{"key":"34655_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","volume":"603","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Bastard, P., Cobat, A. & Casanova, J. L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603, 587\u2013598 (2022).","journal-title":"Nature"},{"key":"34655_CR4","first-page":"14","volume":"1","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. Life-threatening COVID-19: defective interferons unleash excessive inflammation. Med. (N. Y) 1, 14\u201320 (2020).","journal-title":"Med. (N. Y)"},{"key":"34655_CR5","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad, M., Blish, C. A., Sallusto, F. & Iwasaki, A. The immunology and immunopathology of COVID-19. Science 375, 1122\u20131127 (2022).","journal-title":"Science"},{"key":"34655_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark, G. R. et al. How cells respond to interferons. Annu. Rev. Biochem. 67, 227\u2013264 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"34655_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20050821","volume":"202","author":"GA Kolumam","year":"2005","unstructured":"Kolumam, G. A. et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637\u2013650 (2005).","journal-title":"J. Exp. Med."},{"key":"34655_CR8","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/JVI.00985-20","volume":"94","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden, A. et al. Type I and Type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J. Virol. 94, e00985\u201300920 (2020).","journal-title":"J. Virol."},{"key":"34655_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"34655_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","volume":"53","author":"R Zhou","year":"2020","unstructured":"Zhou, R. et al. Acute SARS-CoV-2 infection impairs dendritic cell and T Cell responses. Immunity 53, 864\u2013877.e865 (2020).","journal-title":"Immunity"},{"key":"34655_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27716-4","volume":"13","author":"A Unterman","year":"2022","unstructured":"Unterman, A. et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat. Commun. 13, 440 (2022).","journal-title":"Nat. Commun."},{"key":"34655_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.immuni.2020.04.023","volume":"52","author":"L Ni","year":"2020","unstructured":"Ni, L. et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 52, 971\u2013977.e973 (2020).","journal-title":"Immunity"},{"key":"34655_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"34655_CR14","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, eabd4585 (2020).","journal-title":"Science"},{"key":"34655_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"34655_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25509-3","volume":"12","author":"SE Chang","year":"2021","unstructured":"Chang, S. E. et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat. Commun. 12, 5417 (2021).","journal-title":"Nat. Commun."},{"key":"34655_CR17","doi-asserted-by":"publisher","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, eabc8511 (2020).","journal-title":"Science"},{"key":"34655_CR18","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.4049\/jimmunol.1800267","volume":"201","author":"H Ogura","year":"2018","unstructured":"Ogura, H. et al. Identification and analysis of islet antigen-specific CD8(+) T cells with T cell libraries. J. Immunol. 201, 1662\u20131670 (2018).","journal-title":"J. Immunol."},{"key":"34655_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2567.2004.01853.x","volume":"112","author":"X Yan","year":"2004","unstructured":"Yan, X., Johnson, B. D. & Orentas, R. J. Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo. Immunology 112, 105\u2013116 (2004).","journal-title":"Immunology"},{"key":"34655_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e1415 (2020).","journal-title":"Cell"},{"key":"34655_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes, J., Jongsma, M. L., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823\u2013836 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"34655_CR22","doi-asserted-by":"publisher","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","volume":"34","author":"AT Tan","year":"2021","unstructured":"Tan, A. T. et al. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep. 34, 108728 (2021).","journal-title":"Cell Rep."},{"key":"34655_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/infdis\/jix358","volume":"216","author":"I Tzannou","year":"2017","unstructured":"Tzannou, I. et al. Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy. J. Infect. Dis. 216, 678\u2013687 (2017).","journal-title":"J. Infect. Dis."},{"key":"34655_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","volume":"19","author":"S Sridhar","year":"2013","unstructured":"Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305\u20131312 (2013).","journal-title":"Nat. Med."},{"key":"34655_CR25","doi-asserted-by":"publisher","first-page":"e0115271","DOI":"10.1371\/journal.pone.0115271","volume":"10","author":"JW Steinke","year":"2015","unstructured":"Steinke, J. W. et al. Immune surveillance by rhinovirus-specific circulating CD4+ and CD8+ T lymphocytes. PLoS One 10, e0115271 (2015).","journal-title":"PLoS One"},{"key":"34655_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10224","volume":"6","author":"A Jozwik","year":"2015","unstructured":"Jozwik, A. et al. RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat. Commun. 6, 10224 (2015).","journal-title":"Nat. Commun."},{"key":"34655_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/imm.12548","volume":"147","author":"M Savic","year":"2016","unstructured":"Savic, M. et al. Epitope specific T-cell responses against influenza A in a healthy population. Immunology 147, 165\u2013177 (2016).","journal-title":"Immunology"},{"key":"34655_CR28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012 (2020).","journal-title":"Cell"},{"key":"34655_CR29","doi-asserted-by":"crossref","unstructured":"Rowntree L. C. et al. SARS-CoV-2-specific CD8(+) T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol. Cell Biol. 99, 990-1000 (2021).","DOI":"10.1111\/imcb.12482"},{"key":"34655_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased screens show CD8(+) T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095\u20131107.e1093 (2020).","journal-title":"Immunity"},{"key":"34655_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41577-020-00460-4","volume":"20","author":"M Lipsitch","year":"2020","unstructured":"Lipsitch, M., Grad, Y. H., Sette, A. & Crotty, S. Cross-reactive memory T cells and herd immunity to SARS-CoV-2. Nat. Rev. Immunol. 20, 709\u2013713 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"34655_CR32","doi-asserted-by":"publisher","first-page":"e145476","DOI":"10.1172\/JCI145476","volume":"131","author":"H Kared","year":"2021","unstructured":"Kared, H. et al. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J. Clin. Invest. 131, e145476 (2021).","journal-title":"J. Clin. Invest."},{"key":"34655_CR33","doi-asserted-by":"publisher","first-page":"eabf7550","DOI":"10.1126\/sciimmunol.abf7550","volume":"6","author":"SK Saini","year":"2021","unstructured":"Saini, S. K. et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients. Sci. Immunol. 6, eabf7550 (2021).","journal-title":"Sci. Immunol."},{"key":"34655_CR34","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020).","journal-title":"Front. Immunol."},{"key":"34655_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"JW Song","year":"2020","unstructured":"Song, J. W. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun. 11, 3410 (2020).","journal-title":"Nat. Commun."},{"key":"34655_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"S De Biasi","year":"2020","unstructured":"De Biasi, S. et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat. Commun. 11, 3434 (2020).","journal-title":"Nat. Commun."},{"key":"34655_CR37","doi-asserted-by":"publisher","first-page":"eabe4782","DOI":"10.1126\/sciimmunol.abe4782","volume":"6","author":"A Kusnadi","year":"2021","unstructured":"Kusnadi, A. et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8(+) T cells. Sci. Immunol. 6, eabe4782 (2021).","journal-title":"Sci. Immunol."},{"key":"34655_CR38","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/s41590-020-0791-5","volume":"21","author":"G Galletti","year":"2020","unstructured":"Galletti, G. et al. Two subsets of stem-like CD8(+) memory T cell progenitors with distinct fate commitments in humans. Nat. Immunol. 21, 1552\u20131562 (2020).","journal-title":"Nat. Immunol."},{"key":"34655_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15050","volume":"8","author":"D Wieland","year":"2017","unstructured":"Wieland, D. et al. TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation. Nat. Commun. 8, 15050 (2017).","journal-title":"Nat. Commun."},{"key":"34655_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies, A., Zehn, D. & Utzschneider, D. T. Precursor exhausted T cells: key to successful immunotherapy? Nat. Rev. Immunol. 20, 128\u2013136 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"34655_CR41","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1084\/jem.20180684","volume":"215","author":"J Brummelman","year":"2018","unstructured":"Brummelman, J. et al. High-dimensional single cell analysis identifies stem-like cytotoxic CD8(+) T cells infiltrating human tumors. J. Exp. Med. 215, 2520\u20132535 (2018).","journal-title":"J. Exp. Med."},{"key":"34655_CR42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"34655_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211.e110 (2019).","journal-title":"Immunity"},{"key":"34655_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211\u2013218 (2019).","journal-title":"Nature"},{"key":"34655_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jhep.2019.05.015","volume":"71","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. TOX promotes the exhaustion of antitumor CD8(+) T cells by preventing PD1 degradation in hepatocellular carcinoma. J. Hepatol. 71, 731\u2013741 (2019).","journal-title":"J. Hepatol."},{"key":"34655_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","volume":"571","author":"F Alfei","year":"2019","unstructured":"Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265\u2013269 (2019).","journal-title":"Nature"},{"key":"34655_CR47","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","volume":"571","author":"AC Scott","year":"2019","unstructured":"Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"34655_CR48","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1084\/jem.20090504","volume":"206","author":"R Geiger","year":"2009","unstructured":"Geiger, R., Duhen, T., Lanzavecchia, A. & Sallusto, F. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J. Exp. Med. 206, 1525\u20131534 (2009).","journal-title":"J. Exp. Med."},{"key":"34655_CR49","doi-asserted-by":"publisher","first-page":"287ra274","DOI":"10.1126\/scitranslmed.aaa8038","volume":"7","author":"Y Cao","year":"2015","unstructured":"Cao, Y. et al. Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis. Sci. Transl. Med. 7, 287ra274 (2015).","journal-title":"Sci. Transl. Med."},{"key":"34655_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"34655_CR51","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"34655_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","volume":"601","author":"L Swadling","year":"2022","unstructured":"Swadling, L. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature 601, 110\u2013117 (2022).","journal-title":"Nature"},{"key":"34655_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imm.13451","volume":"166","author":"PR Buckley","year":"2022","unstructured":"Buckley, P. R. et al. HLA-dependent variation in SARS-CoV-2 CD8 (+) T cell cross-reactivity with human coronaviruses. Immunology 166, 78\u2013103 (2022).","journal-title":"Immunology"},{"key":"34655_CR54","first-page":"eabk3070","volume":"7","author":"JM Francis","year":"2022","unstructured":"Francis, J. M. et al. Allelic variation in class I HLA determines CD8(+) T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2. Sci. Immunol. 7, eabk3070 (2022).","journal-title":"Sci. Immunol."},{"key":"34655_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto, M. et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu. Rev. Med. 69, 301\u2013318 (2018).","journal-title":"Annu. Rev. Med."},{"key":"34655_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","volume":"54","author":"MS Rha","year":"2021","unstructured":"Rha, M. S. et al. PD-1-expressing SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity 54, 44\u201352.e43 (2021).","journal-title":"Immunity"},{"key":"34655_CR57","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/s41423-021-00750-4","volume":"18","author":"MS Rha","year":"2021","unstructured":"Rha, M. S. & Shin, E. C. Activation or exhaustion of CD8(+) T cells in patients with COVID-19. Cell Mol. Immunol. 18, 2325\u20132333 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"34655_CR58","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.4049\/jimmunol.1000841","volume":"185","author":"KJ Mackerness","year":"2010","unstructured":"Mackerness, K. J. et al. Pronounced virus-dependent activation drives exhaustion but sustains IFN-\u03b3 transcript levels. J. Immunol. 185, 3643\u20133651 (2010).","journal-title":"J. Immunol."},{"key":"34655_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. An immunodominant NP(105-113)-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 23, 50\u201361 (2022).","journal-title":"Nat. Immunol."},{"key":"34655_CR60","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1084\/jem.20081127","volume":"206","author":"DA Price","year":"2009","unstructured":"Price, D. A. et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J. Exp. Med. 206, 923\u2013936 (2009).","journal-title":"J. Exp. Med."},{"key":"34655_CR61","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1172\/JCI83792","volume":"126","author":"D Benati","year":"2016","unstructured":"Benati, D. et al. Public T cell receptors confer high-avidity CD4 responses to HIV controllers. J. Clin. Invest. 126, 2093\u20132108 (2016).","journal-title":"J. Clin. Invest."},{"key":"34655_CR62","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00262-021-03047-7","volume":"71","author":"YHF Teng","year":"2022","unstructured":"Teng, Y. H. F. et al. Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures. Cancer Immunol. Immunother. 71, 989\u2013998 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"34655_CR63","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.immuni.2020.11.004","volume":"53","author":"AS Shomuradova","year":"2020","unstructured":"Shomuradova, A. S. et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity 53, 1245\u20131257.e1245 (2020).","journal-title":"Immunity"},{"key":"34655_CR64","doi-asserted-by":"publisher","first-page":"e20211327","DOI":"10.1084\/jem.20211327","volume":"218","author":"X Lu","year":"2021","unstructured":"Lu, X. et al. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients. J. Exp. Med. 218, e20211327 (2021).","journal-title":"J. Exp. Med."},{"key":"34655_CR65","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34655_CR66","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1034\/j.1399-0039.2002.590607.x","volume":"59","author":"Y Akatsuka","year":"2002","unstructured":"Akatsuka, Y. et al. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 59, 502\u2013511 (2002).","journal-title":"Tissue Antigens"},{"key":"34655_CR67","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/nm.3358","volume":"19","author":"E Kobayashi","year":"2013","unstructured":"Kobayashi, E. et al. A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days. Nat. Med. 19, 1542\u20131546 (2013).","journal-title":"Nat. Med."},{"key":"34655_CR68","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34655_CR69","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.173.9.5451","volume":"173","author":"T Ueno","year":"2004","unstructured":"Ueno, T. et al. Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J. Immunol. 173, 5451\u20135457 (2004).","journal-title":"J. Immunol."},{"key":"34655_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e289 (2019).","journal-title":"Cell Syst."},{"key":"34655_CR71","doi-asserted-by":"crossref","unstructured":"Le T. et al. BBrowser: making single-cell data easily accessible. bioRxiv, 2020.2012.2011.414136 (2020).","DOI":"10.1101\/2020.12.11.414136"},{"key":"34655_CR72","unstructured":"Cs\u00b7rdi G. b., & Nepusz T. s. The igraph software package for complex network research. (2006)."},{"key":"34655_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2599-6","volume":"20","author":"T Wang","year":"2019","unstructured":"Wang, T., Li, B., Nelson, C. E. & Nabavi, S. Comparative analysis of differential gene expression analysis tools for single-cell RNA sequencing data. BMC Bioinformatics 20, 40 (2019).","journal-title":"BMC Bioinformatics"},{"key":"34655_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496\u2013502 (2019).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34655-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T11:07:39Z","timestamp":1671188859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34655-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,16]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34655"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34655-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,16]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Hyogo Medical University has filed for patent protection for the identification of specific epitopes. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7063"}}